Shuttle Pharmaceuticals Holdings, Inc. Profile Avatar - Palmy Investing

Shuttle Pharmaceuticals Holdings, Inc.

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropi…

Drug Manufacturers - Specialty & Generic
US, Rockville [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Shuttle Pharmaceuticals Holdings, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Shuttle Pharmaceuticals Holdings, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Shuttle Pharmaceuticals Holdings, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of SHPH's Analysis
CIK: 1757499 CUSIP: 825693203 ISIN: US8256932034 LEI: - UEI: -
Secondary Listings
SHPH has no secondary listings inside our databases.